Novo Ventures Leads US$55M Series B Investment in NodThera
Novo Ventures, part of Novo Holdings, today announced that it has led the $55 million (£44 million) Series B financing in NodThera, a UK and US based clinical stage biotechnology company developing a new class of medicines to treat diseases driven by chronic
Solvias Completes Agreement with Strategic Healthcare Investors to Advance Expansion
Solvias Completes Agreement with Strategic Healthcare Investors to Advance Expansion Global Pharmaceutical Laboratory Services Company Appoints Two Seasoned Industry Executives to Board of Directors - Solvias Completes Agreement with Strategic Healthcare Investors to Advance Expansion . Solvias, a world leader in